We are developing a novel class of therapeutics, based on the communication skills of the human gut microbiome, to address immune mediated diseases and disorders. Contact us to find out more.
Location: United Kingdom, England, Reading
Member count: 1-10
Investors 1
| Date | Name | Website |
| - | Namier Cap... | namiercapi... |